“It’s going to be a vibrant session,” said session moderator Nada Jabado, MD, PhD. With these words, the first of two sessions featuring the...
The second day of the AACR Virtual Annual Meeting II began with a clinical trials plenary session. Two of the session’s presentations, which focused on immunotherapy clinical...
Following the resounding success of the First Virtual Annual Meeting with more than 61,000 attendees in April, the AACR...
A study indicates that a sedentary lifestyle increases risk of death from cancer, and more news of the week...
Geriatric assessment improves quality of life in older adults with cancer.
The American Cancer Society issues guidelines for diet and physical activity, and more cancer news of the week from...
Immunotherapy research has exploded over the past decade and has led to the approval of seven immune checkpoint inhibitors by the United States Food and Drug Administration (FDA) for the treatment...
Some people with early-stage non-small cell lung cancer can benefit significantly from treatment with a targeted therapy, and more...
In the early 1990s, Gregg Semenza, MD, PhD, was a postdoctoral researcher studying the cellular response to reduced oxygen levels, a...
A study shows that a more tolerable, dose-adjusted chemotherapy regimen can effectively treat a rare lymphoma, and more news...